Amedisys Inc. Files Q1 2025 10-Q
| Field | Detail |
|---|---|
| Company | Amedisys Inc |
| Form Type | 10-Q |
| Filed Date | Apr 24, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: 10-Q, quarterly-report, healthcare
TL;DR
Amedisys Q1 2025 10-Q filed. Financials and operations detailed.
AI Summary
Amedisys Inc. filed its 10-Q for the period ending March 31, 2025. The filing details the company's financial performance and operational status. Key financial data and operational metrics are presented for the first quarter of 2025, with comparisons to the same period in 2024.
Why It Matters
This filing provides investors and analysts with a detailed look at Amedisys' financial health and operational performance for the first quarter of 2025, enabling informed investment decisions.
Risk Assessment
Risk Level: low — This is a routine quarterly filing providing standard financial and operational information.
Key Numbers
- 2025-03-31 — Period End Date (The end of the reporting period for this 10-Q filing.)
- 2025-01-01 — Period Start Date (The start of the reporting period for this 10-Q filing.)
- 2024-12-31 — Previous Year End Date (The end of the previous fiscal year, often used for comparison.)
Key Players & Entities
- AMEDISYS INC (company) — Filer of the 10-Q
- 20250331 (date) — Conformed period of report
- 20250424 (date) — Filed as of date
- BATON ROUGE (location) — City of business and mail address
FAQ
What is the reporting period for this 10-Q filing?
The conformed period of report is March 31, 2025.
When was this 10-Q filing submitted to the SEC?
The filing was submitted on April 24, 2025.
What is Amedisys Inc.'s primary business classification?
Amedisys Inc. is classified under SERVICES-HOME HEALTH CARE SERVICES [8082].
What is the company's fiscal year end date?
The fiscal year end for Amedisys Inc. is December 31.
What is the interest rate structure mentioned in the filing?
The filing mentions a fluctuating rate per annum equal to the highest of the federal funds rate plus 0.50%, the prime rate, or Term SOFR plus 1%, and a quoted rate equal to SOFR plus a 0.10% adjustment.
Filing Details
This Form 10-Q (Form 10-Q) was filed with the SEC on April 24, 2025 regarding AMEDISYS INC.